Update on Japanese encephalitis vaccine for children: United States, May 2011

    Insights

    The inactivated mouse brain-derived Japanese encephalitis (JE) vaccine (JE-MB), previously the only U.S.-licensed option for children, is unavailable. This notice offers guidance on alternative JE vaccine access for U.S. pediatric populations.

    Area of Science:

    • Immunology
    • Vaccinology
    • Public Health

    Background:

    • The inactivated mouse brain-derived Japanese encephalitis (JE) vaccine (JE-MB), also known as JE-Vax, was the sole JE vaccine approved for pediatric use in the United States.
    • The discontinuation of JE-MB presents a challenge for pediatric Japanese encephalitis prevention in the U.S.

    Purpose of the Study:

    • To inform healthcare providers and the public about the unavailability of the JE-MB vaccine.
    • To provide updated information on available options for obtaining Japanese encephalitis vaccine for children in the United States.

    Main Methods:

    • This is a notice providing updated information, not a research study.
    • Information dissemination regarding vaccine availability and procurement.

    Main Results:

    • The JE-MB vaccine is no longer available for use.
    • Alternative strategies for accessing JE vaccine for U.S. children are being communicated.

    Conclusions:

    • Healthcare providers and parents need to be aware of the JE-MB vaccine's unavailability.
    • Guidance on alternative JE vaccine acquisition is crucial for maintaining pediatric immunization against Japanese encephalitis.

    Related Concept Videos

    Encephalitis l: Introduction01:19

    Encephalitis l: Introduction

    Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
    Arboviral Encephalitis01:25

    Arboviral Encephalitis

    Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    Poliomyelitis01:17

    Poliomyelitis

    Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
    Vaccinations01:51

    Vaccinations

    Overview
    Encephalitis ll: Pathophysiology01:26

    Encephalitis ll: Pathophysiology

    Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...